Legal Representation
Attorney
BRUCE W. BABER
USPTO Deadlines
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 6, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 4, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 4, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 3, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 3, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 3, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 4, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 3, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 3, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 3, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 6, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 4, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 4, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 4, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 4, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 18, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 3, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 24, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 23, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 23, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 23, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 23, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 23, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 10, 2022 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| May 31, 2022 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| May 17, 2022 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| May 17, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 19, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 12, 2022 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Sep 10, 2021 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Sep 10, 2021 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Mar 10, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 10, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 10, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 17, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 16, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 14, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 12, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 28, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 18, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Conjugation-ready kits comprised of assays, reagents, nucleic acids and enzymes used for research purposes
Class 005
Therapeutic medicines, compounds and preparations created using molecular, protein and antibody conjugation and modification technologies used to treat cancer, oncology disorders and conditions, and autoimmune diseases and conditions
Class 042
Research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; Development of therapeutic medicines, compounds and preparations for others
Additional Information
Pseudo Mark
BRICK BIO
Classification
International Classes
001
005
042